Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

  1. Gordilho, J.O.
  2. Miyamoto, D.
  3. Maruta, C.W.
  4. Santo, R.M.
  5. Mahmoud, A.
  6. Navarro-Rodriguez, T.
  7. Werneck-Silva, A.L.
  8. de Aguiar, L.M.
  9. Borges, I.C.
  10. Santi, C.G.
  11. Aoki, V.
Journal:
Journal of the European Academy of Dermatology and Venereology

ISSN: 1468-3083 0926-9959

Year of publication: 2024

Volume: 38

Issue: 1

Pages: e45-e47

Type: Letter

DOI: 10.1111/JDV.19413 GOOGLE SCHOLAR

Sustainable development goals